# MolE: a molecular foundation model for drug discovery

arXiv: https://arxiv.org/abs/2211.02657 · HTML: https://mlsanity.com/paper/2211.02657/

## Key facts

- Cited by 12 papers in the map (data through 14 Oct 2026).
- Builds on 16 of its 39 references that are in the map.
- First posted on arXiv 3 Nov 2022.

## Builds on (most cited first, 16 of 16)

- [Attention Is All You Need](https://mlsanity.com/paper/1706.03762/) (2017)
- [BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding](https://mlsanity.com/paper/1810.04805/) (2018)
- [Language Models are Few-Shot Learners](https://mlsanity.com/paper/2005.14165/) (2020)
- [Semi-Supervised Classification with Graph Convolutional Networks](https://mlsanity.com/paper/1609.02907/) (2016)
- [PaLM: Scaling Language Modeling with Pathways](https://mlsanity.com/paper/2204.02311/) (2022)
- [OPT: Open Pre-trained Transformer Language Models](https://mlsanity.com/paper/2205.01068/) (2022)
- [DeBERTa: Decoding-enhanced BERT with Disentangled Attention](https://mlsanity.com/paper/2006.03654/) (2020)
- [MoleculeNet: A Benchmark for Molecular Machine Learning](https://mlsanity.com/paper/1703.00564/) (2017)
- [Strategies for Pre-training Graph Neural Networks](https://mlsanity.com/paper/1905.12265/) (2019)
- [Convolutional Networks on Graphs for Learning Molecular Fingerprints](https://mlsanity.com/paper/1509.09292/) (2015)
- [Analyzing Learned Molecular Representations for Property Prediction](https://mlsanity.com/paper/1904.01561/) (2019)
- [GuacaMol: Benchmarking Models for De Novo Molecular Design](https://mlsanity.com/paper/1811.09621/) (2018)
- [Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development](https://mlsanity.com/paper/2102.09548/) (2021)
- [ChemBERTa-2: Towards Chemical Foundation Models](https://mlsanity.com/paper/2209.01712/) (2022)
- [Molecular representation learning with language models and domain-relevant auxiliary tasks](https://mlsanity.com/paper/2011.13230/) (2020)
- [Accurate ADMET Prediction with XGBoost](https://mlsanity.com/paper/2204.07532/) (2022)

## Built on by (most cited first, 12 of 12)

- [A Comprehensive Survey of Foundation Models in Medicine](https://mlsanity.com/paper/2406.10729/) (2024)
- [Towards Foundational Models for Molecular Learning on Large-Scale Multi-Task Datasets](https://mlsanity.com/paper/2310.04292/) (2023)
- [On the Scalability of GNNs for Molecular Graphs](https://mlsanity.com/paper/2404.11568/) (2024)
- [Improving Agent Behaviors with RL Fine-tuning for Autonomous Driving](https://mlsanity.com/paper/2409.18343/) (2024)
- [textttMiniMol: A Parameter-Efficient Foundation Model for Molecular Learning](https://mlsanity.com/paper/2404.14986/) (2024)
- [Artificial Intelligence for Drug Discovery: Are We There Yet?](https://mlsanity.com/paper/2307.06521/) (2023)
- [Beyond Efficiency: Molecular Data Pruning for Enhanced Generalization](https://mlsanity.com/paper/2409.01081/) (2024)
- [Aligning Transformers with Weisfeiler-Leman](https://mlsanity.com/paper/2406.03148/) (2024)
- [Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?](https://mlsanity.com/paper/2506.10912/) (2025)
- [Global Human-guided Counterfactual Explanations for Molecular Properties via Reinforcement Learning](https://mlsanity.com/paper/2406.13869/) (2024)
- [Augmenting Molecular Graphs with Geometries via Machine Learning Interatomic Potentials](https://mlsanity.com/paper/2507.00407/) (2025)
- [SWING: Unlocking Implicit Graph Representations for Graph Random Features](https://mlsanity.com/paper/2602.12703/) (2026)

## Abstract (arXiv)

Models that accurately predict properties based on chemical structure are valuable tools in drug discovery. However, for many properties, public and private training sets are typically small, and it is difficult for the models to generalize well outside of the training data. Recently, large language models have addressed this problem by using self-supervised pretraining on large unlabeled datasets, followed by fine-tuning on smaller, labeled datasets. In this paper, we report MolE, a molecular foundation model that adapts the DeBERTa architecture to be used on molecular graphs together with a two-step pretraining strategy. The first step of pretraining is a self-supervised approach focused on learning chemical structures, and the second step is a massive multi-task approach to learn biological information. We show that fine-tuning pretrained MolE achieves state-of-the-art results on 9 of the 22 ADMET tasks included in the Therapeutic Data Commons.
